Conto economico

BIO-TECHNE CORP

TECH
Annual
Riepilogo performance Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
Voce Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Ricavi
1,219.64 1,159.06 1,136.70 1,105.60 931.03 738.69 714.01 - 563.00 499.02 452.25 357.76 310.58 314.56 289.96
Costo del venduto
429.36 389.34 366.89 349.10 298.18 255.50 240.52 210.85 188.46 162.36 144.97 106.35 79.47 78.76 65.03
Utile lordo
790.27 769.73 769.82 756.50 632.85 483.19 473.49 432.14 374.54 336.66 307.28 251.41 231.11 235.80 224.94
Spese operative
688.02 563.04 470.87 459.91 395.55 325.78 326.77 295.97 253.96 186.07 160.25 91.66 72.64 69.60 61.88
Ricerca e sviluppo
99.50 96.66 92.49 87.14 70.60 65.19 62.41 55.33 53.51 45.19 40.85 30.95 29.26 27.91 25.99
Spese commerciali, generali e amministrative
588.52 466.38 378.38 372.77 324.95 260.58 264.36 240.64 200.44 140.88 119.40 60.72 43.38 41.68 35.90
Altre spese operative
- - - - - - - - - - - - - - -
Reddito operativo
102.26 206.69 298.94 296.59 237.30 157.42 146.72 136.18 120.58 150.59 147.02 159.75 158.47 166.21 163.06
Proventi/oneri non operativi
-3.79 -21.00 39.72 4.80 0.51 119.06 -34.70 -10.23 -8.62 -3.11 7.14 1.64 2.19 -4.01 1.93
Proventi da interessi
3.89 - 4.53 - - - - - - - - - - - -
Oneri finanziari
- - 11.22 11.31 13.95 19.20 21.71 10.19 7.36 1.75 1.54 - - - -
Altri proventi/oneri non operativi
0.94 -6.84 -1.10 15.31 -75.64 137.65 -13.57 -0.45 -1.57 -1.61 8.05 -1.04 -0.45 -3.40 -1.83
Risultato prima delle imposte
98.46 185.69 338.66 301.39 148.18 276.48 112.02 125.95 111.96 147.48 154.16 169.86 165.66 170.77 -
Imposte sul reddito
25.06 17.58 53.40 29.34 7.77 47.18 15.94 -0.20 35.88 43.01 -1.70 58.92 53.10 58.43 52.68
Utile di pertinenza di terzi
- - 0.18 -8.95 -0.83 - - - - - - - - - -
Utile netto
73.40 168.11 285.26 272.05 140.41 229.30 -96.07 -126.15 -76.09 104.48 -109.44 110.95 112.56 112.33 112.30
Informazioni supplementari Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
Voce Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Ammortamenti e svalutazioni
- - - - - - - - - - - - - - -
EBITDA
212.16 318.40 406.18 397.66 325.04 240.16 224.89 200.64 180.62 193.36 184.25 178.93 170.79 178.68 171.76
Utile per azione (base)
0.47 1.07 1.81 6.93 3.62 6.00 2.54 3.36 2.04 2.81 2.90 3.01 3.06 3.04 3.03
Utile per azione diluito
0.46 1.05 1.76 6.63 3.47 5.82 2.47 3.31 2.03 2.80 2.89 3.00 3.05 3.04 3.02
Media ponderata azioni
157.52 157.71 157.18 39.22 38.75 38.20 37.78 37.48 37.31 37.19 37.10 36.89 36.84 36.94 37.10
Media ponderata diluita azioni
159.72 160.77 161.86 41.03 40.48 39.40 38.89 38.06 37.50 37.33 37.23 37.01 36.90 37.01 37.17
Conto economico complessivo
91.84 155.85 294.40 254.14 180.32 215.62 82.05 130.27 97.56 64.66 82.53 91.01 105.34 150.40 117.25